Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: Comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone

Bone Marrow Transplantation

Volumn 15, Issue 3, 1995, Pages 401-405

  Leelasiri, A ^a   Greer, J P ^a   Stein, R S ^a   Goodman, S ^a   Brandt, S A ^a   Edwards, J R ^a   Wolff, S N ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prophylaxis; Transplantation; Unrelated donor

Indexed keywords

CYCLOSPORIN; FOLINIC ACID; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMAN; INCIDENCE; INFECTION; MALE; METHOTREXATE; METHYLPREDNISOLONE; SURVIVAL RATE;

EID: 0028960807     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)